: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Breast Cancer

Free Subscription

Articles published in PLoS One
Retrieve available abstracts of 423 articles:
HTML format

Single Articles

January 2024

BUGA A, Harper DG, Sapper TN, Hyde PN, et al
Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.
PLoS One. 2024;19:e0296523.
PubMed Abstract available

VAGNINI D, Natalucci V, Moi S, Vallorani L, et al
Home-based lifestyle intervention for breast cancer survivors: A surprising improvement in the quality of life during the first year of COVID-19 pandemic.
PLoS One. 2024;19:e0296163.
PubMed Abstract available

CHEN X, Li H
Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets.
PLoS One. 2024;19:e0297203.
PubMed Abstract available

LYONS-RAHILLY T, Meskell P, Carey E, Meade E, et al
Exploring the experiences of women living with metastatic breast cancer [MBC]: A systematic review of qualitative evidence.
PLoS One. 2024;19:e0296384.
PubMed Abstract available

GAO W, Sun L, Gai J, Cao Y, et al
Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis.
PLoS One. 2024;19:e0297260.
PubMed Abstract available

MIGOWSKI A, Nadanovsky P, Manso de Mello Vianna C
Harms and benefits of mammographic screening for breast cancer in Brazil.
PLoS One. 2024;19:e0297048.
PubMed Abstract available

SHAHMIRZALOU P, Rasekhi A, Jafari Khaledi M, Khayamzadeh M, et al
Comparison performance of the Bayesian Approach with the Weibull and Birnbaum-Saunders distributions in imputation of time-to-event censors.
PLoS One. 2024;19:e0295977.
PubMed Abstract available

ZARIF S, Abdulkader H, Elaraby I, Alharbi A, et al
Using hybrid pre-trained models for breast cancer detection.
PLoS One. 2024;19:e0296912.
PubMed Abstract available

SINKALA M, Naran K, Ramamurthy D, Mungra N, et al
Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects.
PLoS One. 2024;19:e0296511.
PubMed Abstract available

PIEDRA-DELGADO L, Chambergo-Michilot D, Morante Z, Fairen C, et al
Survival according to the site of metastasis in triple-negative breast cancer patients: The Peruvian experience.
PLoS One. 2024;19:e0293833.
PubMed Abstract available

PUVVULA PK, Moon AM
Discovery and characterization of anti-cancer peptides from a random peptide library.
PLoS One. 2024;19:e0293072.
PubMed Abstract available

RAGHURAM GV, Pal K, Sriram G, Khan A, et al
Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
PLoS One. 2024;19:e0298042.
PubMed Abstract available

SVENDSEN SMS, Pedersen DC, Jensen BW, Aarestrup J, et al
Early life body size and puberty markers as predictors of breast cancer risk later in life: A neural network analysis.
PLoS One. 2024;19:e0296835.
PubMed Abstract available

KUO ET, Kuo C, Lin CL
Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.
PLoS One. 2024;19:e0289519.
PubMed Abstract available

NYAMHANGA T, Eustace RW, Makoye JP, Mutalemwa K, et al
Multi-level barriers to early detection of breast cancer among rural midlife women in Tanzania: A qualitative case study.
PLoS One. 2024;19:e0297798.
PubMed Abstract available

MILLER JL, Reddy A, Harman RM, Van de Walle GR, et al
A xenotransplantation mouse model to study physiology of the mammary gland from large mammals.
PLoS One. 2024;19:e0298390.
PubMed Abstract available

XIA Q, Shen J, Wang Q, Chen R, et al
Cuproptosis-associated ncRNAs predict breast cancer subtypes.
PLoS One. 2024;19:e0299138.
PubMed Abstract available

BAKER R, Dell'Acqua G, Richards A, Thornton MJ, et al
Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
PLoS One. 2024;19:e0297080.
PubMed Abstract available

WIRANATA JA, Hutajulu SH, Astari YK, Leo B, et al
Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer.
PLoS One. 2024;19:e0298928.
PubMed Abstract available

TAOMA K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T, et al
Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy.
PLoS One. 2024;19:e0298788.
PubMed Abstract available

ABDUL REHMAN M, Tahir E, Ghulam Hussain H, Khalid A, et al
Awareness regarding breast cancer amongst women in Pakistan: A systematic review and meta-analysis.
PLoS One. 2024;19:e0298275.
PubMed Abstract available

WAHLSTROM E, Audisio RA, Selvaggi G
Aspects to consider regarding breast cancer risk in trans men: A systematic review and risk management approach.
PLoS One. 2024;19:e0299333.
PubMed Abstract available

KESSLER LG, Comstock B, Aiello Bowles EJ, Mou J, et al
Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design.
PLoS One. 2024;19:e0297773.
PubMed Abstract available

NGUYEN AQ, Tran OTM, Nguyen PK, Nguyen HT, et al
Cost-effectiveness of one-year adjuvant trastuzumab therapy in treatment for early-stage breast cancer patients with HER2+ in Vietnam.
PLoS One. 2024;19:e0300474.
PubMed Abstract available

NORTHGRAVES M, Cohen J, Harvey J, Huang C, et al
A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) - Study protocol.
PLoS One. 2024;19:e0300339.
PubMed Abstract available

ZHU JJ, Huang FY, Chen H, Zhang YL, et al
Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.
PLoS One. 2024;19:e0299571.
PubMed Abstract available

BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
PLoS One. 2024;19:e0298583.
PubMed Abstract available

OTTO AK, Prinsloo S, Natori A, Wagner RW, et al
Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.
PLoS One. 2024;19:e0297077.
PubMed Abstract available

NIU X, Wang J, Liu J, Yu Q, et al
17beta-Estradiol promotes metastasis in triple-negative breast cancer through the Calpain/YAP/beta-catenin signaling axis.
PLoS One. 2024;19:e0298184.
PubMed Abstract available

EBRAHIMPOUR-KOUJAN S, Benisi-Kohansal S, Azadbakht L, Fallah M, et al
Adherence to HEI-2010 and odds of breast cancer according to the menopause status: Evidence from Middle Eastern Country.
PLoS One. 2024;19:e0300986.
PubMed Abstract available

DEMEKE T, Hailemariam D, Santos P, Seife E, et al
Willingness and ability to pay for breast cancer treatment among patients from Addis Ababa, Ethiopia: A cross-sectional study.
PLoS One. 2024;19:e0300631.
PubMed Abstract available

RAGHURAM GV, Pal K, Sriram G, Khan A, et al
Correction: Therapeutic interventions on human breast cancer xenografts promote systemic dissemination of oncogenes.
PLoS One. 2024;19:e0301650.
PubMed Abstract available

Retraction: Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
PLoS One. 2024;19:e0300804.
PubMed

KANG ES, Lim YC, Jang BH, Lee YJ, et al
Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
PLoS One. 2024;19:e0298270.
PubMed Abstract available

FONSECA-ALVES CE, Leis-Filho AF, Lacerda ZA, de Faria Lainetti P, et al
Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells.
PLoS One. 2024;19:e0297043.
PubMed Abstract available

ZHU K, Sui Y, Zhu M, Gao Y, et al
Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
PLoS One. 2024;19:e0301057.
PubMed Abstract available

ALHASSAN AM
An improved breast cancer classification with hybrid chaotic sand cat and Remora Optimization feature selection algorithm.
PLoS One. 2024;19:e0300622.
PubMed Abstract available

SLOJEWSKA K, Galbarczyk A, Klimek M, Tubek-Krokosz A, et al
Higher number of steps is related to lower endogenous progesterone but not estradiol levels in women.
PLoS One. 2024;19:e0299580.
PubMed Abstract available

BAHCACI U, Atasavun Uysal S, Erdogan Iyigun Z, Ordu C, et al
Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial.
PLoS One. 2024;19:e0301020.
PubMed Abstract available

ABIDI O, Abdelkafi-Koubaa Z, Bettaieb-Dridi I, Toumi L, et al
Pistacia lentiscus L. revealed in vitro anti-proliferative activity on MCF-7 breast cancer cells and in vivo anti-mammary cancer effect on C57BL/6 mice through necrosis, anti-inflammatory and antioxidant enhancements.
PLoS One. 2024;19:e0301524.
PubMed Abstract available

ERDOGAN C, Suer I, Kaya M, Ozturk S, et al
Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network in breast cancer.
PLoS One. 2024;19:e0301995.
PubMed Abstract available

ALLANA A, Shamsi U, Rashid Y, Khan FR, et al
Oral mucositis & oral health related quality of life in women undergoing chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based cross-sectional study.
PLoS One. 2024;19:e0295456.
PubMed Abstract available

EUM DY, Jeong M, Park SY, Kim J, et al
AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells.
PLoS One. 2024;19:e0296989.
PubMed Abstract available

January 2023

DAMMU H, Ren T, Duong TQ
Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
PLoS One. 2023;18:e0280148.
PubMed Abstract available

YUAN Y, Liu X, Cai Y, Li W, et al
Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.
PLoS One. 2023;18:e0279775.
PubMed Abstract available

ISLAM N, Bhuiyan AKMMR, Alam A, Chowdhury MK, et al
Coping strategy among the women with metastatic breast cancer attending a palliative care unit of a tertiary care hospital of Bangladesh.
PLoS One. 2023;18:e0278620.
PubMed Abstract available

Retraction: Synthesis, Characterization and In Vitro Study of Biocompatible Cinnamaldehyde Functionalized Magnetite Nanoparticles (CPGF Nps) For Hyperthermia and Drug Delivery Applications in Breast Cancer.
PLoS One. 2023;18:e0280492.
PubMed

HU G, Ding Q, Zhong K, Wang S, et al
Low pretreatment prognostic nutritional index predicts poor survival in breast cancer patients: A meta-analysis.
PLoS One. 2023;18:e0280669.
PubMed Abstract available

ZHENG H, Ge C, Lin H, Zhou S, et al
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.
PLoS One. 2023;18:e0280474.
PubMed Abstract available

FLOOD E, Krasnow A, Orbegoso C, Karantzoulis S, et al
Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancer.
PLoS One. 2023;18:e0280259.
PubMed Abstract available

SYED A, Adam R, Ren T, Lu J, et al
Machine learning with textural analysis of longitudinal multiparametric MRI and molecular subtypes accurately predicts pathologic complete response in patients with invasive breast cancer.
PLoS One. 2023;18:e0280320.
PubMed Abstract available

JANG SJ, Moon C
Aquaporin 5 (AQP5) expression in breast cancer and its clinicopathological characteristics.
PLoS One. 2023;18:e0270752.
PubMed Abstract available

NORMANN LS, Haugen MH, Hongisto V, Aure MR, et al
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer.
PLoS One. 2023;18:e0280507.
PubMed Abstract available

WU R, Luo J, Wan H, Zhang H, et al
Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database.
PLoS One. 2023;18:e0280340.
PubMed Abstract available

MISGANAW M, Zeleke H, Mulugeta H, Assefa B, et al
Mortality rate and predictors among patients with breast cancer at a referral hospital in northwest Ethiopia: A retrospective follow-up study.
PLoS One. 2023;18:e0279656.
PubMed Abstract available

HE Y, Chen S, Gao X, Fu L, et al
Robustness of VMAT to setup errors in postmastectomy radiotherapy of left-sided breast cancer: Impact of bolus thickness.
PLoS One. 2023;18:e0280456.
PubMed Abstract available

WESTHOFF CC, Muller SK, Jank P, Kalder M, et al
Nodal lymphangiogenesis and immunophenotypic variations of sinus endothelium in sentinel and non-sentinel lymph nodes of invasive breast carcinoma.
PLoS One. 2023;18:e0280936.
PubMed Abstract available

YAN B, Shi R, Lu YY, Fang DD, et al
Shenqi Fuzheng injection reverses M2 macrophage-mediated cisplatin resistance through the PI3K pathway in breast cancer.
PLoS One. 2023;18:e0279752.
PubMed Abstract available

LOPEZ-PANISELLO MB, Perez-Lacasta MJ, Rue M, Carles-Lavila M, et al
Factors influencing intention to participate in breast cancer screening. An exploratory structural model.
PLoS One. 2023;18:e0281454.
PubMed Abstract available

LIU R, Ospanova S, Perry RJ
The impact of variance in carnitine palmitoyltransferase-1 expression on breast cancer prognosis is stratified by clinical and anthropometric factors.
PLoS One. 2023;18:e0281252.
PubMed Abstract available

DHAKAL R, Adhikari C, Karki P, Neupane N, et al
Attitude sustains longer than subjective norm and perceived behavioral control: Results of breast cancer screening educational intervention.
PLoS One. 2023;18:e0281184.
PubMed Abstract available

RODRIGUEZ IJ, Bernal-Estevez DA, Llano-Leon M, Bonilla CE, et al
Neoadjuvant chemotherapy modulates exhaustion of T cells in breast cancer patients.
PLoS One. 2023;18:e0280851.
PubMed Abstract available

JAYASEKERA LP, Ranasinghe R, Senathilake KS, Kotelawala JT, et al
Mitochondrial genome in sporadic breast cancer: A case control study and a proteomic analysis in a Sinhalese cohort from Sri Lanka.
PLoS One. 2023;18:e0281620.
PubMed Abstract available

BOUCHMAA N, Ben Mrid R, Bouargalne Y, Ajouaoi S, et al
In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer.
PLoS One. 2023;18:e0272781.
PubMed Abstract available

DELGADO AB, Tylden ES, Lukic M, Moi L, et al
Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
PLoS One. 2023;18:e0281218.
PubMed Abstract available

MAPANGA W, Norris SA, Craig A, Ayeni OA, et al
Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort.
PLoS One. 2023;18:e0281916.
PubMed Abstract available

ALMEIDA SS, Oliveira MA, Medeiros R, Guerra MP, et al
Emotional, inflammatory, and genetic factors of resilience and vulnerability to depression in patients with premenopausal breast cancer: A longitudinal study protocol.
PLoS One. 2023;18:e0279344.
PubMed Abstract available

GONG W, Fang P, Leng M, Shi Y, et al
Promoting GSDME expression through DNA demethylation to increase chemosensitivity of breast cancer MCF-7 / Taxol cells.
PLoS One. 2023;18:e0282244.
PubMed Abstract available

LESER C, Dorffner G, Marhold M, Rutter A, et al
Liver function indicators in patients with breast cancer before and after detection of hepatic metastases-a retrospective study.
PLoS One. 2023;18:e0278454.
PubMed Abstract available

PADAMSEE TJ, Muraveva A, Meadows RJ, Hils M, et al
Racial differences in prevention decision making among U.S. women at high risk of breast cancer: A qualitative study.
PLoS One. 2023;18:e0278742.
PubMed Abstract available

FROST CJ, Ramirez-Mata A, Khattri RB, Merritt ME, et al
Effects of beta-caryophyllene and oxygen availability on cholesterol and fatty acids in breast cancer cells.
PLoS One. 2023;18:e0281396.
PubMed Abstract available

LI Z, Wang Q, Xu J, Song Q, et al
Comparative efficacy and acceptability of interventions for insomnia in breast cancer patients: A protocol for systematic review and network meta-analysis.
PLoS One. 2023;18:e0282614.
PubMed Abstract available

SHITA A, Yalew AW, Seife E, Afework T, et al
Survival and predictors of breast cancer mortality in South Ethiopia: A retrospective cohort study.
PLoS One. 2023;18:e0282746.
PubMed Abstract available

SCHOUSTRA SM, De Santi B, Op 't Root TJPM, Klazen CAH, et al
Imaging breast malignancies with the Twente Photoacoustic Mammoscope 2.
PLoS One. 2023;18:e0281434.
PubMed Abstract available

LIU P, Roberts S, Shoemaker JT, Vukasinovic J, et al
Validation of a 3D perfused cell culture platform as a tool for humanised preclinical drug testing in breast cancer using established cell lines and patient-derived tissues.
PLoS One. 2023;18:e0283044.
PubMed Abstract available

ALMESHARI M, Alzamil Y, Alyahyawi A, Abanomy A, et al
Awareness level, knowledge and attitude towards breast cancer among staff and students of Hail University, Saudi Arabia.
PLoS One. 2023;18:e0282916.
PubMed Abstract available

Retraction: Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation.
PLoS One. 2023;18:e0283354.
PubMed

ROCHE S, Gaule P, Winrow D, Mukherjee N, et al
Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer.
PLoS One. 2023;18:e0282512.
PubMed Abstract available

CHEN R, Li P, Fu Y, Wu Z, et al
Chaperone-mediated autophagy promotes breast cancer angiogenesis via regulation of aerobic glycolysis.
PLoS One. 2023;18:e0281577.
PubMed Abstract available

PARKER G, Hunter S, Ghazi S, Hayeems RZ, et al
Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review.
PLoS One. 2023;18:e0280582.
PubMed Abstract available

LEE JJ, Choi HR, Choi EP, Ho MH, et al
Psychometric evaluation of Korean version of COVID-19 fear scale (K-FS-8): A population based cross-sectional study.
PLoS One. 2023;18:e0282589.
PubMed Abstract available

Retraction: Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-kappaB Activation.
PLoS One. 2023;18:e0283750.
PubMed

LEHTONEN AJ, Arasalo O, Srbova L, Heilala M, et al
Magnetic microrheometry of tumor-relevant stiffness levels and probabilistic quantification of viscoelasticity differences inside 3D cell culture matrices.
PLoS One. 2023;18:e0282511.
PubMed Abstract available

GORDON JAR, Evans MF, Ghule PN, Lee K, et al
Identification of molecularly unique tumor-associated mesenchymal stromal cells in breast cancer patients.
PLoS One. 2023;18:e0282473.
PubMed Abstract available

CHEN J
Timed hazard networks: Incorporating temporal difference for oncogenetic analysis.
PLoS One. 2023;18:e0283004.
PubMed Abstract available

MADISON AA, Filatov M, Andridge R, Haas G, et al
A troubled heart: Mood disorder history longitudinally predicts faster cardiopulmonary aging in breast cancer survivorship.
PLoS One. 2023;18:e0283849.
PubMed Abstract available

ODA H, Hedayati E, Lindstrom A, Shabo I, et al
GATA-3 expression in breast cancer is related to intratumoral M2 macrophage infiltration and tumor differentiation.
PLoS One. 2023;18:e0283003.
PubMed Abstract available

THIESEN AP, Mielczarski B, Savaris RF
Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
PLoS One. 2023;18:e0282176.
PubMed Abstract available

YU J, Gao Y, Wang H, Liu B, et al
Structural equation modeling analysis of determinants of barriers to breast self-examination among Eastern Chinese women.
PLoS One. 2023;18:e0283525.
PubMed Abstract available

DING L, Yang Y, Chi M, Chen Z, et al
Diagnostic role of heart rate variability in breast cancer and its relationship with peripheral serum carcinoembryonic antigen.
PLoS One. 2023;18:e0282221.
PubMed Abstract available

RAAT EM, Evans KK
Early signs of cancer present in the fine detail of mammograms.
PLoS One. 2023;18:e0282872.
PubMed Abstract available

SU Z, Niazi MKK, Tavolara TE, Niu S, et al
BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
PLoS One. 2023;18:e0283562.
PubMed Abstract available

VASSILEV I, Lin SX, Calman L, Turner J, et al
The role of social networks in the self-management support for young women recently diagnosed with breast cancer.
PLoS One. 2023;18:e0282183.
PubMed Abstract available

PAGE LL, Kahn CJ, Severson J, Kramer AF, et al
Physical activity and cognitive function: A comparison of rural and urban breast cancer survivors.
PLoS One. 2023;18:e0284189.
PubMed Abstract available

ASLAM A, Arshad Z, Ahmed A, Soh CL, et al
Bilateral risk-reducing mastectomy and reconstruction-A 12-year review of methodological trends and outcomes at a tertiary referral centre.
PLoS One. 2023;18:e0281601.
PubMed Abstract available

Retraction: Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.
PLoS One. 2023;18:e0284594.
PubMed

LLANO-LEON M, Martinez-Enriquez LC, Rodriguez-Bohorquez OM, Velandia-Vargas EA, et al
Effect of neoadjuvant chemotherapy on tumor immune infiltration in breast cancer patients: Systematic review and meta-analysis.
PLoS One. 2023;18:e0277714.
PubMed Abstract available

CARVALHO SM, Andrade CA, Ferreira MBLS, de Souza KSS, et al
Women's perception about the discovery of breast cancer amid the covid-19 pandemic.
PLoS One. 2023;18:e0282610.
PubMed Abstract available

WESTERN B, Demmelmaier I, Vistad I, Hansen BH, et al
How many days of continuous physical activity monitoring reliably represent time in different intensities in cancer survivors.
PLoS One. 2023;18:e0284881.
PubMed Abstract available

BO MC, Merlo A, Ligabue MB, Bassi MC, et al
Self-managed physical activity in breast cancer survivors: A scoping review.
PLoS One. 2023;18:e0284807.
PubMed Abstract available

XU H, Shao X, Hui S, Jin L, et al
Supervised breast cancer prediction using integrated dimensionality reduction convolutional neural network.
PLoS One. 2023;18:e0282350.
PubMed Abstract available

SHARMA D, Tarapacki CM, Kandavel H, Panchalingam M, et al
Evaluating the effects of radiation and acoustically-stimulated microbubble therapy in an in vivo breast cancer model.
PLoS One. 2023;18:e0277759.
PubMed Abstract available

BATES-FRASER LC, Riley S, Stopforth C, Moertl K, et al
Home-based exercise improves quality of life in breast and prostate cancer survivors: A meta-analysis.
PLoS One. 2023;18:e0284427.
PubMed Abstract available

HIATT RA, Worden L, Rehkopf D, Engmann N, et al
A complex systems model of breast cancer etiology: The Paradigm II Model.
PLoS One. 2023;18:e0282878.
PubMed Abstract available

AMER NN, Khairat R, Hammad AM, Kamel MM, et al
DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
PLoS One. 2023;18:e0284455.
PubMed Abstract available

BEN REKAYA M, Sassi F, Saied E, Bel Haj Kacem L, et al
PIK3CA mutations in breast cancer: A Tunisian series.
PLoS One. 2023;18:e0285413.
PubMed Abstract available

JI X, Li R, Hu X, Tian Y, et al
Construction of model animals to explore intestinal microbiome for detection of breast cancer.
PLoS One. 2023;18:e0280971.
PubMed Abstract available

ZHUANG L, Chen Q, Chen H, Zheng X, et al
Breast cancer-related lymphedema and recurrence of breast cancer: Protocol for a prospective cohort study in China.
PLoS One. 2023;18:e0285772.
PubMed Abstract available

STOCKER A, Mehnert-Theuerkauf A, Hinz A, Ernst J, et al
Utilization of complementary and alternative medicine (CAM) by women with breast cancer or gynecological cancer.
PLoS One. 2023;18:e0285718.
PubMed Abstract available

ARAMAKI S, Tsuge S, Islam A, Eto F, et al
Lipidomics-based tissue heterogeneity in specimens of luminal breast cancer revealed by clustering analysis of mass spectrometry imaging: A preliminary study.
PLoS One. 2023;18:e0283155.
PubMed Abstract available

MUSHEYEV D, Miller E, Birnbaum N, Miller E, et al
Inhibition of ERK signaling for treatment of ERRalpha positive TNBC.
PLoS One. 2023;18:e0283047.
PubMed Abstract available

WISESTY UN, Mengko TR, Purwarianti A, Pancoro A, et al
Temporal convolutional network for a Fast DNA mutation detection in breast cancer data.
PLoS One. 2023;18:e0285981.
PubMed Abstract available

Expression of Concern: MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis.
PLoS One. 2023;18:e0286445.
PubMed

WU X, Wabitsch M, Yang J, Sakharkar MK, et al
Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells.
PLoS One. 2023;18:e0286111.
PubMed Abstract available

SHIBAHARA T, Wada C, Yamashita Y, Fujita K, et al
Deep learning generates custom-made logistic regression models for explaining how breast cancer subtypes are classified.
PLoS One. 2023;18:e0286072.
PubMed Abstract available

ALANAZI SM, Feroz W, Mishra R, Kilroy MK, et al
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.
PLoS One. 2023;18:e0285251.
PubMed Abstract available

KWAN JM, Arbune A, Henry ML, Hu R, et al
Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
PLoS One. 2023;18:e0286364.
PubMed Abstract available

JAAMOUR A, Myles C, Patel A, Chen SJ, et al
A divide and conquer approach to maximise deep learning mammography classification accuracies.
PLoS One. 2023;18:e0280841.
PubMed Abstract available

DA SILVA BR, Rufato S, Mialich MS, Cruz LP, et al
Phase angle is related to oxidative stress and antioxidant biomarkers in breast cancer patients undergoing chemotherapy.
PLoS One. 2023;18:e0283235.
PubMed Abstract available

VAINER G, Huang L, Emancipator K, Nuti S, et al
Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
PLoS One. 2023;18:e0285764.
PubMed Abstract available

B K M, Kaphle HP
Breast self-examination: Knowledge, practice and associated factors among 20 to 49 years aged women in Butwal sub-metropolitan, Rupandehi, Nepal.
PLoS One. 2023;18:e0286676.
PubMed Abstract available

OMISORE AD, Olasehinde O, Wuraola FO, Sutton EJ, et al
Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol.
PLoS One. 2023;18:e0284341.
PubMed Abstract available

ENGEL S, Jacobsen HB, Reme SE
A cross-sectional study of fear of surgery in female breast cancer patients: Prevalence, severity, and sources, as well as relevant differences among patients experiencing high, moderate, and low fear of surgery.
PLoS One. 2023;18:e0287641.
PubMed Abstract available

SHAFIK N, Ilmonen P, Viitasaari L, Sarkeala T, et al
Flexible transition probability model for assessing cost-effectiveness of breast cancer screening extension to include women aged 45-49 and 70-74.
PLoS One. 2023;18:e0287486.
PubMed Abstract available

YANG Q, Li F, Jia G, Liu R, et al
Aged black garlic extract inhibits the growth of estrogen receptor-positive breast cancer cells by downregulating MCL-1 expression through the ROS-JNK pathway.
PLoS One. 2023;18:e0286454.
PubMed Abstract available

SHIN KH, Ah YM, Cha SH, Choi HD, et al
Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data.
PLoS One. 2023;18:e0287382.
PubMed Abstract available

REN Z, Easley TO, Pineda FD, Guo X, et al
Pharmacokinetic Analysis of Enhancement-Constrained Acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI.
PLoS One. 2023;18:e0286123.
PubMed Abstract available

SKJERVOLD AH, Valla M, Ytterhus B, Bofin AM, et al
PAK1 copy number in breast cancer-Associations with proliferation and molecular subtypes.
PLoS One. 2023;18:e0287608.
PubMed Abstract available

LEE KH, Hwang HJ, Im YJ, Nam AR, et al
New oncogenic functions of LINE1 retroelement as a ceRNA for tumor suppressive microRNA miR-126 on ENPP5.
PLoS One. 2023;18:e0286814.
PubMed Abstract available

NG B, Puspitaningtyas H, Wiranata JA, Hutajulu SH, et al
Breast cancer incidence in Yogyakarta, Indonesia from 2008-2019: A cross-sectional study using trend analysis and geographical information system.
PLoS One. 2023;18:e0288073.
PubMed Abstract available

LESLIE A, Teh E, Druker A, Pinto DM, et al
A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients.
PLoS One. 2023;18:e0281491.
PubMed Abstract available

CAREDDA E, Pedini G, D'Amico F, Scioli MG, et al
FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis.
PLoS One. 2023;18:e0287062.
PubMed Abstract available

SUN G, Yan X, Wang H, Li F, et al
Color restoration based on digital pathology image.
PLoS One. 2023;18:e0287704.
PubMed Abstract available

MASSEY S, Khan MA, Rab SO, Mustafa S, et al
Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients.
PLoS One. 2023;18:e0288482.
PubMed Abstract available

COSAR R, Sut N, Topaloglu S, Tastekin E, et al
Classifying invasive lobular carcinoma as special type breast cancer may be reducing its treatment success: A comparison of survival among invasive lobular carcinoma, invasive ductal carcinoma, and no-lobular special type breast cancer.
PLoS One. 2023;18:e0283445.
PubMed Abstract available

MANSOOR Q, Ismail M, Ali Ul Qader S
Linkage disequilibrium block single-nucleotide polymorphisms in FTO alpha ketoglutarate dependent dioxygenase gene inference with breast cancer and Type II diabetes in Pakistani female population.
PLoS One. 2023;18:e0288934.
PubMed Abstract available

SAWMYNADEN K, Wong N, Davies S, Cowan R, et al
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool.
PLoS One. 2023;18:e0288259.
PubMed Abstract available

HSU SW, Chiang SC, Hsu JC, Ko Y, et al
Prescription patterns of granulocyte colony-stimulating factors in patients with breast cancer: A real-world study.
PLoS One. 2023;18:e0288642.
PubMed Abstract available

SANCHEZ-BAYUELA DA, Ghavami N, Tiberi G, Sani L, et al
A multicentric, single arm, prospective, stratified clinical investigation to evaluate MammoWave's ability in breast lesions detection.
PLoS One. 2023;18:e0288312.
PubMed Abstract available

LEE YJ, Yoo TK, Kim J, Chung IY, et al
Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype.
PLoS One. 2023;18:e0284460.
PubMed Abstract available

FISCON G, Funari A, Paci P
Circular RNA mediated gene regulation in human breast cancer: A bioinformatics analysis.
PLoS One. 2023;18:e0289051.
PubMed Abstract available

JAVAN BIPARVA A, Raoofi S, Rafiei S, Masoumi M, et al
Global depression in breast cancer patients: Systematic review and meta-analysis.
PLoS One. 2023;18:e0287372.
PubMed Abstract available

FANG Q, Xin W, Chen L, Fu Y, et al
Caffeic acid phenethyl ester suppresses metastasis of breast cancer cells by inactivating FGFR1 via MD2.
PLoS One. 2023;18:e0289031.
PubMed Abstract available

OZ M, King JR, Yang KS, Khushaish S, et al
alpha7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.
PLoS One. 2023;18:e0289098.
PubMed Abstract available

NICKEL B, McCaffery K, Jansen J, Barratt A, et al
Women's views about current and future management of Ductal Carcinoma in Situ (DCIS): A mixed-methods study.
PLoS One. 2023;18:e0288972.
PubMed Abstract available

LIN C, He J, Tong X, Song L, et al
Copper homeostasis-associated gene PRNP regulates ferroptosis and immune infiltration in breast cancer.
PLoS One. 2023;18:e0288091.
PubMed Abstract available

KAIDAR-PERSON O, Antunes M, Cardoso JS, Ciani O, et al
Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: The CINDERELLA trial.
PLoS One. 2023;18:e0289365.
PubMed Abstract available

CHEN C, Wang R, Wang B, Wu Y, et al
The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer.
PLoS One. 2023;18:e0288078.
PubMed Abstract available

GHEMRAWI R, Al Qassem A, Ramadan A, Aldulaymi R, et al
DNA and protein methyltransferases inhibition by adenosine dialdehyde reduces the proliferation and migration of breast and lung cancer cells by downregulating autophagy.
PLoS One. 2023;18:e0288791.
PubMed Abstract available

XU C, Lu P, Pfob A, Pusic AL, et al
Physical well-being recovery trajectories by reconstruction modality in women undergoing mastectomy and breast reconstruction: Significant predictors and health-related quality of life outcomes.
PLoS One. 2023;18:e0289182.
PubMed Abstract available

DURRANI IA, Bhatti A, John P
Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
PLoS One. 2023;18:e0289839.
PubMed Abstract available

LEE H, Jung S, Gong G, Lim B, et al
Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer.
PLoS One. 2023;18:e0289627.
PubMed Abstract available

LEE YW, Ahn SH, Lee YJ, Yoo TK, et al
Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
PLoS One. 2023;18:e0290174.
PubMed Abstract available

SIBEONI J, Manolios E, Mathe J, Feka V, et al
The experience of a program combining two complementary therapies for women with breast cancer: An IPSE qualitative study.
PLoS One. 2023;18:e0285617.
PubMed Abstract available

DING J, Li C, Shu K, Chen W, et al
Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.
PLoS One. 2023;18:e0289960.
PubMed Abstract available

FERNANDEZ-GUALDA MA, Ariza-Vega P, Lozano-Lozano M, Cantarero-Villanueva I, et al
Persistent pain management in an oncology population through pain neuroscience education, a multimodal program: PaiNEd randomized clinical trial protocol.
PLoS One. 2023;18:e0290096.
PubMed Abstract available

SHOAIB TH, Ibraheem W, Abdelrahman M, Osman W, et al
Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies.
PLoS One. 2023;18:e0289887.
PubMed Abstract available

WANG D, Gao L, Gao X, Wang C, et al
Identification of monotonically expressed long non-coding RNA signatures for breast cancer using variational autoencoders.
PLoS One. 2023;18:e0289971.
PubMed Abstract available

FLECK JL, Hooijenga D, Phan R, Xie X, et al
Adjuvant therapeutic strategy decision support for an elderly population with localized breast cancer: A monocentric cohort retrospective study.
PLoS One. 2023;18:e0290566.
PubMed Abstract available

SHI D, Liang X, Li Y, Chen L, et al
Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer.
PLoS One. 2023;18:e0290507.
PubMed Abstract available

NOR S, Chan KG, Rahman HA, H Abdul-Mumin K, et al
Patient satisfaction of breast reconstructive surgery following mastectomy in Brunei.
PLoS One. 2023;18:e0289955.
PubMed Abstract available

GONG M, Shen F, Li Y, Ming L, et al
MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
PLoS One. 2023;18:e0290462.
PubMed Abstract available

CUI Y, Lu W, Shao T, Zhuo Z, et al
Severe mental illness and the risk of breast cancer: A two-sample, two-step multivariable Mendelian randomization study.
PLoS One. 2023;18:e0291006.
PubMed Abstract available

NADEEM H, Romley JA, Warren Andersen S
Reduced racial disparity in receipt of optimal locoregional treatment for women with early-stage breast cancer.
PLoS One. 2023;18:e0291025.
PubMed Abstract available

AL-KAFAJI G, Jassim G, AlHajeri A, Alawadhi AMT, et al
Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based-multigene panel.
PLoS One. 2023;18:e0291015.
PubMed Abstract available

AB MUMIN N, Ramli Hamid MT, Abdul Hamid S, Chiew SF, et al
Magnetic resonance imaging features of invasive breast cancer association with the tumour stromal ratio.
PLoS One. 2023;18:e0290772.
PubMed Abstract available

MAZUMDER H, Husain M, Hossain MF, Mahmud S, et al
Prevalence, trend and associated factors of obesity-related cancers among U.S. adults with metabolic syndrome: Evidence from the National Health and Nutrition Examination Survey 2001-2018.
PLoS One. 2023;18:e0290994.
PubMed Abstract available

BULUT G, Atilgan HI, Cinarer G, Kilic K, et al
Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT.
PLoS One. 2023;18:e0290543.
PubMed Abstract available

SOHAIL S, Burns MB
Integrating current analyses of the breast cancer microbiome.
PLoS One. 2023;18:e0291320.
PubMed Abstract available

YOUSIF FA, Alzain AA, Alraih AM, Ibraheem W, et al
Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies.
PLoS One. 2023;18:e0291256.
PubMed Abstract available

SCHOENHALS S, Mali ME, Sutherland EK, Sorenson J, et al
Geospatial availability of breast cancer treatment modalities and hypothetical access improvement in Ghana: A nationwide survey.
PLoS One. 2023;18:e0291454.
PubMed Abstract available

LAFI Z, Alshaer W, Gharaibeh L, Alqudah DA, et al
Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line.
PLoS One. 2023;18:e0291981.
PubMed Abstract available

CHAU OW, El-Sherif O, Mouawad M, Sykes JM, et al
Changes in myocardial blood flow in a canine model of left sided breast cancer radiotherapy.
PLoS One. 2023;18:e0291854.
PubMed Abstract available

XIA YT, Zhang YQ, Chen L, Min L, et al
Suppression of migration and invasion by taraxerol in the triple-negative breast cancer cell line MDA-MB-231 via the ERK/Slug axis.
PLoS One. 2023;18:e0291693.
PubMed Abstract available

AKASH S, Aovi FI, Azad MAK, Kumer A, et al
A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
PLoS One. 2023;18:e0283271.
PubMed Abstract available

RAMSHANKAR G, Liu R, Perry RJ
The association between the amino acid transporter LAT1, tumor immunometabolic and proliferative features and menopausal status in breast cancer.
PLoS One. 2023;18:e0292678.
PubMed Abstract available

NDINGURI M, Middleton L, Unrine J, Lui S, et al
Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
PLoS One. 2023;18:e0287151.
PubMed Abstract available

CABARCAS-PETROSKI S, Olshefsky G, Schramm L
MAF1 is a predictive biomarker in HER2 positive breast cancer.
PLoS One. 2023;18:e0291549.
PubMed Abstract available

SCHLIEMANN D, Jamil ASA, Mohan D, Tan MM, et al
The development and evaluation of a mHealth, community education and navigation intervention to improve clinical breast examination uptake in Segamat Malaysia: A randomised controlled trial.
PLoS One. 2023;18:e0288437.
PubMed Abstract available

GAO X, Zhang F, Zhou Q, Xu H, et al
Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.
PLoS One. 2023;18:e0293830.
PubMed Abstract available

ZHOU H, Cai Z, Yang Q, Yang X, et al
Inflammatory cytokines and two subtypes of breast cancer: A two-sample mendelian randomization study.
PLoS One. 2023;18:e0293230.
PubMed Abstract available

BOJANIC C, Di Pace B, Ghorra DT, Fopp LJ, et al
A comparison of presentations and outcomes of salvage versus non-salvage abdominal free flap breast reconstructions-Results of a 15-year tertiary referral centre review.
PLoS One. 2023;18:e0288364.
PubMed Abstract available

FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
PLoS One. 2023;18:e0278011.
PubMed Abstract available

PARK SY, Park JM, Kim JI, Choi CH, et al
Quantitative radiomics approach to assess acute radiation dermatitis in breast cancer patients.
PLoS One. 2023;18:e0293071.
PubMed Abstract available

DA SILVA SA R, Von Ah Rodrigues RF, Bugalho LA, da Silva SU, et al
Evaluation of the efficacy of using indocyanine green associated with fluorescence in sentinel lymph node biopsy.
PLoS One. 2023;18:e0273886.
PubMed Abstract available

SARTORETTI E, Largiader S, Sartoretti T, Laures S, et al
Understanding the needs of women undergoing breast ultrasound: Are male radiologists still needed?
PLoS One. 2023;18:e0291007.
PubMed Abstract available

JEANMARD N, Bissanum R, Sriplung H, Charoenlappanit S, et al
Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women.
PLoS One. 2023;18:e0291574.
PubMed Abstract available

MAGARA MS, Mungazi SG, Gonde P, Nare H, et al
Factors leading to the late diagnosis and poor outcomes of breast cancer in Matabeleland South and the Bulawayo Metropolitan Provinces in Zimbabwe.
PLoS One. 2023;18:e0292169.
PubMed Abstract available

VON HIPPEL C, Dibble KE, Rosenberg SM, Bollman-Jenkins M, et al
Taking their wellbeing into their own hands: Self-educated and peer-recommended techniques used by women with breast cancer to improve sexual functioning during treatment and in survivorship.
PLoS One. 2023;18:e0293298.
PubMed Abstract available

SATAGOPAN JM, Dharamdasani T, Mathur S, Kohler RE, et al
Experiences and lessons learned from community-engaged recruitment for the South Asian breast cancer study in New Jersey during the COVID-19 pandemic.
PLoS One. 2023;18:e0294170.
PubMed Abstract available

ZAMANI N, Szymiczek A, Shakeri R, Poustchi H, et al
A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
PLoS One. 2023;18:e0292611.
PubMed Abstract available

HWANG HJ, Lee TG
Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
PLoS One. 2023;18:e0294649.
PubMed Abstract available

BITTER EE, Skidmore J, Allen CI, Erickson RI, et al
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells.
PLoS One. 2023;18:e0293128.
PubMed Abstract available

ZHAO Y, Wang W, Li J, Du J, et al
Elevated expression of TUBA1C in breast cancer predicts poor prognosis.
PLoS One. 2023;18:e0263710.
PubMed Abstract available

DUBOWITZ J, Ziegler AI, Beare R, Jost-Brinkmann F, et al
Type of anesthesia for cancer resection surgery: No differential impact on cancer recurrence in mouse models of breast cancer.
PLoS One. 2023;18:e0293905.
PubMed Abstract available

Retraction: Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a.
PLoS One. 2023;18:e0295991.
PubMed

PLANTE A, Gauvin L, Sabiston CM, Dore I, et al
Perceived autonomy support from healthcare professionals and physical activity among breast cancer survivors: A propensity score analysis.
PLoS One. 2023;18:e0295751.
PubMed Abstract available

MOGHTADERI S, Mandapati A, Davies G, Wahid KA, et al
Smart and low-cost fluorometer for identifying breast cancer malignancy based on lipid droplets accumulation.
PLoS One. 2023;18:e0294988.
PubMed Abstract available

YANG Y, Zhang Y, Tang Y, Zhang J, et al
Anesthesia-related intervention for long-term survival and cancer recurrence following breast cancer surgery: A systematic review of prospective studies.
PLoS One. 2023;18:e0296158.
PubMed Abstract available

WANG P, Zhang Q, Zhang H, Shao J, et al
Molecular and clinical characterization of ICOS expression in breast cancer through large-scale transcriptome data.
PLoS One. 2023;18:e0293469.
PubMed Abstract available

FONTANA F, Esser AK, Egbulefu C, Karmakar P, et al
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.
PLoS One. 2023;18:e0293700.
PubMed Abstract available

Retraction: Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer.
PLoS One. 2023;18:e0296553.
PubMed

January 2022

MASCIA F, Mazo I, Alterovitz WL, Karagiannis K, et al
In search of autophagy biomarkers in breast cancer: Receptor status and drug agnostic transcriptional changes during autophagy flux in cell lines.
PLoS One. 2022;17:e0262134.
PubMed Abstract available

MOHAMED EA, Rashed EA, Gaber T, Karam O, et al
Deep learning model for fully automated breast cancer detection system from thermograms.
PLoS One. 2022;17:e0262349.
PubMed Abstract available

HUTAJULU SH, Prabandari YS, Bintoro BS, Wiranata JA, et al
Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: A retrospective observational study.
PLoS One. 2022;17:e0262468.
PubMed Abstract available

ZAHRAN AM, Rayan A, Zahran ZAM, Mohamed WMY, et al
Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
PLoS One. 2022;17:e0262650.
PubMed Abstract available

HOZHABRI H, Ghasemi Dehkohneh RS, Razavi SM, Razavi SM, et al
Comparative analysis of protein-protein interaction networks in metastatic breast cancer.
PLoS One. 2022;17:e0260584.
PubMed Abstract available

SILVA DAS
Hospitalization and ambulatory costs related to breast cancer due to physical inactivity in the Brazilian state capitals.
PLoS One. 2022;17:e0261019.
PubMed Abstract available

CAO X, Li Y, Wang Y, Yu T, et al
Curcumin suppresses tumorigenesis by ferroptosis in breast cancer.
PLoS One. 2022;17:e0261370.
PubMed Abstract available

MURAYAMA MA, Takada E, Takai K, Arimitsu N, et al
Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells.
PLoS One. 2022;17:e0260838.
PubMed Abstract available

TOMAS RC, Sayat AJ, Atienza AN, Danganan JL, et al
Detection of breast cancer by ATR-FTIR spectroscopy using artificial neural networks.
PLoS One. 2022;17:e0262489.
PubMed Abstract available

SHI D, Li H, Zhang Z, He Y, et al
Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.
PLoS One. 2022;17:e0262389.
PubMed Abstract available

HUSSAIN I, Majeed A, Masood I, Ashraf W, et al
A national survey to assess breast cancer awareness among the female university students of Pakistan.
PLoS One. 2022;17:e0262030.
PubMed Abstract available

RAJAGOPAL T, Seshachalam A, Rathnam KK, Talluri S, et al
Homologous recombination DNA repair gene RAD51, XRCC2 & XRCC3 polymorphisms and breast cancer risk in South Indian women.
PLoS One. 2022;17:e0259761.
PubMed Abstract available

LAZA-VASQUEZ C, Codern-Bove N, Cardona-Cardona A, Hernandez-Leal MJ, et al
Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.
PLoS One. 2022;17:e0263788.
PubMed Abstract available

TSUI TCO, Trudeau M, Mitsakakis N, Torres S, et al
Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
PLoS One. 2022;17:e0262635.
PubMed Abstract available

MARQUES AD, Moura AR, Hora EC, Brito EAC, et al
Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.
PLoS One. 2022;17:e0263222.
PubMed Abstract available

HESARI E, Ahmadinezhad M, Arshadi M, Azizi H, et al
The association between migraine and breast cancer risk: A systematic review and meta-analysis.
PLoS One. 2022;17:e0263628.
PubMed Abstract available

TSCHODU D, Ulm B, Bendrat K, Lippoldt J, et al
Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature.
PLoS One. 2022;17:e0261035.
PubMed Abstract available

AKOKO LO, Rutashobya AK, Lutainulwa EW, Mwanga AH, et al
The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among black Tanzanian women: A case control study.
PLoS One. 2022;17:e0263374.
PubMed Abstract available

KILBAS PO, Can ND, Kizilboga T, Ezberci F, et al
CRISPR/Cas9-mediated Bag-1 knockout increased mesenchymal characteristics of MCF-7 cells via Akt hyperactivation-mediated actin cytoskeleton remodeling.
PLoS One. 2022;17:e0261062.
PubMed Abstract available

LV Z, Zhang W, Zhang Y, Zhong G, et al
Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study.
PLoS One. 2022;17:e0263104.
PubMed Abstract available

PADMANABHAN H, Hassan NT, Wong SW, Lee YQ, et al
Psychosocial outcome and health behaviour intent of breast cancer patients with BRCA1/2 and PALB2 pathogenic variants unselected by a priori risk.
PLoS One. 2022;17:e0263675.
PubMed Abstract available

CONTE F, Sibilio P, Grimaldi AM, Salvatore M, et al
In silico recognition of a prognostic signature in basal-like breast cancer patients.
PLoS One. 2022;17:e0264024.
PubMed Abstract available

MARKELLOS C, Ourailidou ME, Gavriatopoulou M, Halvatsiotis P, et al
Olive oil intake and cancer risk: A systematic review and meta-analysis.
PLoS One. 2022;17:e0261649.
PubMed Abstract available

NELSON DR, Brown J, Morikawa A, Method M, et al
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics.
PLoS One. 2022;17:e0264637.
PubMed Abstract available

TSAI CJ, Huang HY, Chen FM, Yang YH, et al
Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ.
PLoS One. 2022;17:e0262934.
PubMed Abstract available

MAHMOOD T, Li J, Pei Y, Akhtar F, et al
Breast lesions classifications of mammographic images using a deep convolutional neural network-based approach.
PLoS One. 2022;17:e0263126.
PubMed Abstract available

KWON D, Ko BK, Jung SP, Kim HK, et al
Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
PLoS One. 2022;17:e0262709.
PubMed Abstract available

TROUGHTON LD, O'Loughlin DA, Zech T, Hamill KJ, et al
Laminin N-terminus alpha31 is upregulated in invasive ductal breast cancer and changes the mode of tumour invasion.
PLoS One. 2022;17:e0264430.
PubMed Abstract available

KOLODZIEJ M, Kaznowska E, Paszek S, Cebulski J, et al
Characterisation of breast cancer molecular signature and treatment assessment with vibrational spectroscopy and chemometric approach.
PLoS One. 2022;17:e0264347.
PubMed Abstract available

KIM H, Lee SB, Kim J, Chung IY, et al
Improvement of survival in Korean breast cancer patients over a 14-year period: A large-scale single-center study.
PLoS One. 2022;17:e0265533.
PubMed Abstract available

XU X, Soulos PR, Herrin J, Wang SY, et al
Perioperative magnetic resonance imaging in breast cancer care: Distinct adoption trajectories among physician patient-sharing networks.
PLoS One. 2022;17:e0265188.
PubMed Abstract available

SHI SC, Zhang Y, Wang T
High RRM2 expression has poor prognosis in specific types of breast cancer.
PLoS One. 2022;17:e0265195.
PubMed Abstract available

ZHU J, Oh JH, Deasy JO, Tannenbaum AR, et al
vWCluster: Vector-valued optimal transport for network based clustering using multi-omics data in breast cancer.
PLoS One. 2022;17:e0265150.
PubMed Abstract available

BOUJEMAA M, Mighri N, Chouchane L, Boubaker MS, et al
Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
PLoS One. 2022;17:e0265638.
PubMed Abstract available

LIU J, Ho PJ, Tan THL, Yeoh YS, et al
BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.
PLoS One. 2022;17:e0265965.
PubMed Abstract available

BOMMI-REDDY A, Park-Chouinard S, Mayhew DN, Terzo E, et al
CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells.
PLoS One. 2022;17:e0262378.
PubMed Abstract available

CHUAYCHAI A, Sriplung H
A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.
PLoS One. 2022;17:e0265417.
PubMed Abstract available

ULLAH F, Khurshid N, Fatimi Q, Loidl P, et al
Mutations in the acetylation hotspots of Rbl2 are associated with increased risk of breast cancer.
PLoS One. 2022;17:e0266196.
PubMed Abstract available

FLORES-GARCIA LC, Ventura-Gallegos JL, Romero-Cordoba SL, Hernandez-Juarez AJ, et al
Sera from women with different metabolic and menopause states differentially regulate cell viability and Akt activation in a breast cancer in-vitro model.
PLoS One. 2022;17:e0266073.
PubMed Abstract available

PETROCCHI S, Ongaro G, Calvello M, Feroce I, et al
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
PLoS One. 2022;17:e0266327.
PubMed Abstract available

FILIPOWICZ N, Drezek K, Horbacz M, Wojdak A, et al
Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
PLoS One. 2022;17:e0266111.
PubMed Abstract available

ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
PLoS One. 2022;17:e0261069.
PubMed Abstract available

CHEN PC, Lee YC, Su YC, Lee CH, et al
Does hepatectomy improve outcomes of breast cancer with liver metastasis? A nationwide analysis of real-world data in Taiwan.
PLoS One. 2022;17:e0266960.
PubMed Abstract available

PEREZ CS, Mestriner C, Ribeiro LTN, Grillo FW, et al
Relationship between lymphedema after breast cancer treatment and biophysical characteristics of the affected tissue.
PLoS One. 2022;17:e0264160.
PubMed Abstract available

SQUARA PA, Luu VP, Perol D, Coudert B, et al
Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.
PLoS One. 2022;17:e0267242.
PubMed Abstract available

HU H, Qiao S, Hao Y, Bai Y, et al
Breast cancer histopathological images recognition based on two-stage nuclei segmentation strategy.
PLoS One. 2022;17:e0266973.
PubMed Abstract available

NUNEZ-RUIZ A, Sanchez-Brena F, Lopez-Pacheco C, Acevedo-Dominguez NA, et al
Obesity modulates the immune macroenvironment associated with breast cancer development.
PLoS One. 2022;17:e0266827.
PubMed Abstract available

AI H
GSEA-SDBE: A gene selection method for breast cancer classification based on GSEA and analyzing differences in performance metrics.
PLoS One. 2022;17:e0263171.
PubMed Abstract available

DAILY A, Ravishankar P, Harms S, Klimberg VS, et al
Using tears as a non-invasive source for early detection of breast cancer.
PLoS One. 2022;17:e0267676.
PubMed Abstract available

TZELVES L, Manolitsis I, Varkarakis I, Ivanovic M, et al
Artificial intelligence supporting cancer patients across Europe-The ASCAPE project.
PLoS One. 2022;17:e0265127.
PubMed Abstract available

PARK SY, Kim JH, Chang JH, Park JM, et al
Quantitative evaluation of radiodermatitis following whole-breast radiotherapy with various color space models: A feasibility study.
PLoS One. 2022;17:e0264925.
PubMed Abstract available

ARORA I, Sharma M, Li S, Crowley M, et al
An integrated analysis of the effects of maternal broccoli sprouts exposure on transcriptome and methylome in prevention of offspring mammary cancer.
PLoS One. 2022;17:e0264858.
PubMed Abstract available

LOPEZ-JIMENEZ T, Duarte-Salles T, Plana-Ripoll O, Recalde M, et al
Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control study.
PLoS One. 2022;17:e0264634.
PubMed Abstract available

HAO Y, Zhang L, Qiao S, Bai Y, et al
Breast cancer histopathological images classification based on deep semantic features and gray level co-occurrence matrix.
PLoS One. 2022;17:e0267955.
PubMed Abstract available

KOYAMA K, Ishikawa H, Abe M, Shiose Y, et al
Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression.
PLoS One. 2022;17:e0267027.
PubMed Abstract available

LI T, Li Y, Yang Y, Li J, et al
Logistic regression analysis of ultrasound findings in predicting the malignant and benign phyllodes tumor of breast.
PLoS One. 2022;17:e0265952.
PubMed Abstract available

UEDA D, Yamamoto A, Onoda N, Takashima T, et al
Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets.
PLoS One. 2022;17:e0265751.
PubMed Abstract available

OSE N, Takeuchi Y, Sakamaki Y, Kadota Y, et al
Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay.
PLoS One. 2022;17:e0265603.
PubMed Abstract available

ANNONI AM, Longhini C
Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
PLoS One. 2022;17:e0265387.
PubMed Abstract available

TAGHIZADEH MS, Niazi A, Moghadam A, Afsharifar A, et al
Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer.
PLoS One. 2022;17:e0267961.
PubMed Abstract available

DAMASCENO KA, Santos-Conceicao AMD, Silva LP, Cardoso TMS, et al
Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma.
PLoS One. 2022;17:e0267648.
PubMed Abstract available

SCHLIEMANN D, Hoe WMK, Mohan D, Allotey P, et al
Challenges and opportunities for breast cancer early detection among rural dwelling women in Segamat District, Malaysia: A qualitative study.
PLoS One. 2022;17:e0267308.
PubMed Abstract available

MEDINA HN, Callahan KE, Koru-Sengul T, Maheshwari S, et al
Elevated breast cancer mortality among highly educated Asian American women.
PLoS One. 2022;17:e0268617.
PubMed Abstract available

MA L, Bian M, Gao H, Zhou Z, et al
A novel 3-acyl isoquinolin-1(2H)-one induces G2 phase arrest, apoptosis and GSDME-dependent pyroptosis in breast cancer.
PLoS One. 2022;17:e0268060.
PubMed Abstract available

CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
PLoS One. 2022;17:e0265881.
PubMed Abstract available

ALAM MS, Sultana A, Reza MS, Amanullah M, et al
Integrated bioinformatics and statistical approaches to explore molecular biomarkers for breast cancer diagnosis, prognosis and therapies.
PLoS One. 2022;17:e0268967.
PubMed Abstract available

ZEMNI I, Kacem M, Dhouib W, Bennasrallah C, et al
Breast cancer incidence and predictions (Monastir, Tunisia: 2002-2030): A registry-based study.
PLoS One. 2022;17:e0268035.
PubMed Abstract available

GRANT E, Bucklain FA, Ginn L, Laity P, et al
Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines.
PLoS One. 2022;17:e0268300.
PubMed Abstract available

ONAGA C, Tamori S, Matsuoka I, Ozaki A, et al
High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.
PLoS One. 2022;17:e0268799.
PubMed Abstract available

NGAN TT, Jenkins C, Minh HV, Donnelly M, et al
Breast cancer screening practices among Vietnamese women and factors associated with clinical breast examination uptake.
PLoS One. 2022;17:e0269228.
PubMed Abstract available

TRAN T, Le U, Shi Y
An effective up-sampling approach for breast cancer prediction with imbalanced data: A machine learning model-based comparative analysis.
PLoS One. 2022;17:e0269135.
PubMed Abstract available

NAM KH, Lee JH, Chung YS, Chun YS, et al
The efficacy of oxidized regenerated cellulose (SurgiGuard(R)) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.
PLoS One. 2022;17:e0267694.
PubMed Abstract available

MEURS CJC, Til JAV, Menke-Pluijmers MBE, Vet S, et al
Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.
PLoS One. 2022;17:e0269551.
PubMed Abstract available

TANDA N, Tada H, Washio J, Takahashi N, et al
Influence of alcohol sensitivity on bone metastases and skeletal-related events in primary operable breast cancer: A retrospective cohort study.
PLoS One. 2022;17:e0269335.
PubMed Abstract available

XIA LY, Xu WY, Zhao Y
Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
PLoS One. 2022;17:e0270528.
PubMed Abstract available

PUSPITANINGTYAS H, Sulistyoningrum DC, Witaningrum R, Widodo I, et al
Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia.
PLoS One. 2022;17:e0270507.
PubMed Abstract available

HARDEMAN AA, Han YJ, Grushko TA, Mueller J, et al
Subtype-specific expression of MELK is partly due to copy number alterations in breast cancer.
PLoS One. 2022;17:e0268693.
PubMed Abstract available

SILVA DA COSTA N, Alves da Silva AS, de Melo-Neto JS
Effects of dance therapy in women with breast cancer: A systematic review protocol.
PLoS One. 2022;17:e0257948.
PubMed Abstract available

PIEMONTESE A, Galvain T, Swindells L, Parago V, et al
Budget impact analysis of HARMONIC FOCUS+ Shears for mastectomy and breast-conserving surgery with axillary lymph node dissection compared with monopolar electrocautery from an Italian hospital perspective.
PLoS One. 2022;17:e0268708.
PubMed Abstract available

PARK J, Kim C, Ki Y, Kim W, et al
Incidence of hypothyroidism after treatment for breast cancer: A Korean population-based study.
PLoS One. 2022;17:e0269893.
PubMed Abstract available

MENG X, Wang L, He M, Yang Z, et al
Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
PLoS One. 2022;17:e0269998.
PubMed Abstract available

SARKER R, Islam MS, Moonajilin MS, Rahman M, et al
Knowledge of breast cancer and breast self-examination practices and its barriers among university female students in Bangladesh: Findings from a cross-sectional study.
PLoS One. 2022;17:e0270417.
PubMed Abstract available

COX A, Martini A, Ghozlan H, Moroose R, et al
Chaperonin containing TCP1 as a marker for identification of circulating tumor cells in blood.
PLoS One. 2022;17:e0264651.
PubMed Abstract available

REME SE, Munk A, Holter MTS, Falk RS, et al
Pre- and post-operative psychological interventions to prevent pain and fatigue after breast cancer surgery (PREVENT): Protocol for a randomized controlled trial.
PLoS One. 2022;17:e0268606.
PubMed Abstract available

MELLOR P, Kendall S, Smith S, Saxena A, et al
Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
PLoS One. 2022;17:e0271090.
PubMed Abstract available

CZUBAK-PROWIZOR K, Macieja A, Poplawski T, Zbikowska HM, et al
Responses of human colon and breast adenocarcinoma cell lines (LoVo, MCF7) and non-tumorigenic mammary epithelial cells (MCF-10A) to the acellular fraction of packed red blood cells in the presence and absence of cisplatin.
PLoS One. 2022;17:e0271193.
PubMed Abstract available

MESSIER TL, Boyd JR, Gordon JAR, Tye CE, et al
Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
PLoS One. 2022;17:e0271725.
PubMed Abstract available

CONTI B, Bochaton A, Charreire H, Kitzis-Bonsang H, et al
Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.
PLoS One. 2022;17:e0271319.
PubMed Abstract available

DIOSAN L, Andreica A, Voiculescu I
On the use of multi-objective evolutionary classifiers for breast cancer detection.
PLoS One. 2022;17:e0269950.
PubMed Abstract available

YANG Z, Liu J, Wang Q
Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.
PLoS One. 2022;17:e0270347.
PubMed Abstract available

ACEA-NEBRIL B, Garcia-Novoa A, Garcia Jimenez L
The PreQ-20 TRIAL: A prospective cohort study of the oncologic safety, quality of life and cosmetic outcomes of patients undergoing prepectoral breast reconstruction.
PLoS One. 2022;17:e0269426.
PubMed Abstract available

FUNGA ML, Dilebo ZD, Shuramo AG, Bereku T, et al
Assessing breast cancer awareness on reproductive age women in West Badewacho Woreda, Hadiyya Zone, South Ethiopia; Community based cross- sectional study.
PLoS One. 2022;17:e0270248.
PubMed Abstract available

CHEN CC, Ho WL, Lin CH, Chen HH, et al
Stratified analysis of the association between periodontitis and female breast cancer based on age, comorbidities and level of urbanization: A population-based nested case-control study.
PLoS One. 2022;17:e0271948.
PubMed Abstract available

DEY M, Rana SP, Loretoni R, Duranti M, et al
Automated breast lesion localisation in microwave imaging employing simplified pulse coupled neural network.
PLoS One. 2022;17:e0271377.
PubMed Abstract available

WANG J, Chen X, Wang L, Zhang C, et al
Does aquatic physical therapy affect the rehabilitation of breast cancer in women? A systematic review and meta-analysis of randomized controlled trials.
PLoS One. 2022;17:e0272337.
PubMed Abstract available

KHAJAH MA, Khushaish S, Luqmani YA
Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro.
PLoS One. 2022;17:e0272449.
PubMed Abstract available

LAZAR IM, Karcini A, Haueis JRS
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks.
PLoS One. 2022;17:e0272384.
PubMed Abstract available

PE KCS, Saetung R, Yodsurang V, Chaotham C, et al
Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
PLoS One. 2022;17:e0273044.
PubMed Abstract available

YANG Y, Lin Y, Sikapokoo GO, Min SH, et al
Social relationships and their associations with affective symptoms of women with breast cancer: A scoping review.
PLoS One. 2022;17:e0272649.
PubMed Abstract available

AYNALEM M, Adem N, Wendesson F, Misganaw B, et al
Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center.
PLoS One. 2022;17:e0271895.
PubMed Abstract available

NISHI K, Fu W, Kiyama R
Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.
PLoS One. 2022;17:e0273164.
PubMed Abstract available

YANG K, Suzuki A, Ye J, Nosato H, et al
CTG-Net: Cross-task guided network for breast ultrasound diagnosis.
PLoS One. 2022;17:e0271106.
PubMed Abstract available

HLAING MT, Horimoto Y, Denda-Nagai K, Fujihira H, et al
Tamoxifen-resistant breast cancer cells exhibit reactivity with Wisteria floribunda agglutinin.
PLoS One. 2022;17:e0273513.
PubMed Abstract available

SLAGHMUYLDER Y, Pype P, Van Hecke A, Lauwerier E, et al
Exploring healthcare providers' perceptions regarding the prevention and treatment of chronic pain in breast cancer survivors: A qualitative analysis among different disciplines.
PLoS One. 2022;17:e0273576.
PubMed Abstract available

BEAUBRUN-RENARD MM, Veronique-Baudin J, Macni J, Ulric-Gervaise S, et al
Overall survival of triple negative breast cancer in French Caribbean women.
PLoS One. 2022;17:e0271966.
PubMed Abstract available

KEMBOI D, Langat MK, Siwe-Noundou X, Tshiwawa T, et al
13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico.
PLoS One. 2022;17:e0271389.
PubMed Abstract available

Retraction: Vascular Endothelial Growth Factor Receptor-1 Activation Promotes Migration and Invasion of Breast Cancer Cells through Epithelial-Mesenchymal Transition.
PLoS One. 2022;17:e0274216.
PubMed

VICENTE-MUNOZ S, Hunt BG, Lange TE, Wells SI, et al
NMR-based metabolomic analysis identifies RON-DEK-beta-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
PLoS One. 2022;17:e0274128.
PubMed Abstract available

VAN GOGH S, Mukherjee S, Xu J, Wang Z, et al
Iterative phase contrast CT reconstruction with novel tomographic operator and data-driven prior.
PLoS One. 2022;17:e0272963.
PubMed Abstract available

MEYER SB, Lunnay B, Warin M, Foley K, et al
Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk.
PLoS One. 2022;17:e0270936.
PubMed Abstract available

MIGHRI N, Mejri N, Boujemaa M, Berrazega Y, et al
Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients.
PLoS One. 2022;17:e0269732.
PubMed Abstract available

AL-SANEA MM, Chilingaryan G, Abelyan N, Mamikonyan M, et al
Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors.
PLoS One. 2022;17:e0272065.
PubMed Abstract available

STAAF J, Aine M
Tumor purity adjusted beta values improve biological interpretability of high-dimensional DNA methylation data.
PLoS One. 2022;17:e0265557.
PubMed Abstract available

LEE C, Kim S, Woo J
A comparative analysis of factors influencing colorectal cancer's age standardized mortality ratio among Korean women in the hot and cold spots.
PLoS One. 2022;17:e0273995.
PubMed Abstract available

SUN D, Li C, Zhang F
MicroRNA-206 suppresses growth and metastasis of breast cancer stem cells via blocking EVI-1-mediated CALR expression.
PLoS One. 2022;17:e0274919.
PubMed Abstract available

RAHPEIMA R, Lin CA
Numerical study of magnetic hyperthermia ablation of breast tumor on an anatomically realistic breast phantom.
PLoS One. 2022;17:e0274801.
PubMed Abstract available

ASSFA MOSSA K
Perceptions and knowledge of breast cancer and breast self-examination among young adult women in southwest Ethiopia: Application of the health belief model.
PLoS One. 2022;17:e0274935.
PubMed Abstract available

ZHUANG L, Chen H, Zheng X, Wu S, et al
Bioelectrical impedance analysis for early screening of upper limb subclinical lymphedema: A case-control study.
PLoS One. 2022;17:e0274570.
PubMed Abstract available

MASSAFRA R, Comes MC, Bove S, Didonna V, et al
A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
PLoS One. 2022;17:e0274691.
PubMed Abstract available

HAMID AB, Frank LE, Bouley RA, Petreaca RC, et al
Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
PLoS One. 2022;17:e0273736.
PubMed Abstract available

CROZIER M, Tubman J, Fifield BA, Ferraiuolo RM, et al
Frequently used antiemetic agent dexamethasone enhances the metastatic behaviour of select breast cancer cells.
PLoS One. 2022;17:e0274675.
PubMed Abstract available

LEE R, Lee HB, Paeng JC, Choi H, et al
Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer.
PLoS One. 2022;17:e0275279.
PubMed Abstract available

RODALLEC A, Vaghi C, Ciccolini J, Fanciullino R, et al
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.
PLoS One. 2022;17:e0274886.
PubMed Abstract available

ROSERO G, Pattarone G, Penaherera A, Pilz J, et al
Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1).
PLoS One. 2022;17:e0274911.
PubMed Abstract available

IBRAHIM EY, Munshani S, Domenicano I, Rodwin R, et al
A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy.
PLoS One. 2022;17:e0275648.
PubMed Abstract available

GOWTHAM HG, Murali M, Singh SB, Shivamallu C, et al
Phytoconstituents of Withania somnifera unveiled Ashwagandhanolide as a potential drug targeting breast cancer: Investigations through computational, molecular docking and conceptual DFT studies.
PLoS One. 2022;17:e0275432.
PubMed Abstract available

SAKAFU LL, Philipo GS, Malichewe CV, Fundikira LS, et al
Delayed diagnostic evaluation of symptomatic breast cancer in sub-Saharan Africa: A qualitative study of Tanzanian women.
PLoS One. 2022;17:e0275639.
PubMed Abstract available

DEMEKE T, Ayele W, Haile Mariam D, Wienke A, et al
Health system cost of breast cancer treatment in Addis Ababa, Ethiopia.
PLoS One. 2022;17:e0275171.
PubMed Abstract available

HARIKRISHNAN K, Prabhu SS, Balasubramanian N
A pan-cancer analysis of matrisome proteins reveals CTHRC1 and a related network as major ECM regulators across cancers.
PLoS One. 2022;17:e0270063.
PubMed Abstract available

NAM KE, Kim I, Park HY, Lee JI, et al
The effect of breast cancer surgery on spine alignment: Whole-spine radiograph analysis.
PLoS One. 2022;17:e0276173.
PubMed Abstract available

DE BONIFACE J, Altena R, Haddad Ringborg C, Bolam KA, et al
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial.
PLoS One. 2022;17:e0274804.
PubMed Abstract available

JAGARLAMUDI KK, L S, M Z, J O, et al
Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
PLoS One. 2022;17:e0275444.
PubMed Abstract available

KIBRET YM, Leka YA, Tekle NF, Tigeneh W, et al
Patterns of cancer in Wolaita Sodo University Hospital: South Ethiopia.
PLoS One. 2022;17:e0274792.
PubMed Abstract available

POKORA RM, Buttner M, Schulz A, Schuster AK, et al
Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS).
PLoS One. 2022;17:e0275525.
PubMed Abstract available

A MOHAMED E, Gaber T, Karam O, Rashed EA, et al
A Novel CNN pooling layer for breast cancer segmentation and classification from thermograms.
PLoS One. 2022;17:e0276523.
PubMed Abstract available

CHAN WY, Cheah WK, Ramli Hamid MT, Md Shah MN, et al
Impact of preoperative magnetic resonance imaging on surgery and eligibility for intraoperative radiotherapy in early breast cancer.
PLoS One. 2022;17:e0274385.
PubMed Abstract available

LU J, Chen XM, Xie KH
Effectiveness of nursing interventions on the sexual quality of life of patients with breast cancer: A systematic review and meta-analysis.
PLoS One. 2022;17:e0277221.
PubMed Abstract available

MCDONALD JT, Ricks-Santi LJ
Hereditary variants of unknown significance in African American women with breast cancer.
PLoS One. 2022;17:e0273835.
PubMed Abstract available

HAYAT F, Khan NU, Khan AU, Ahmad I, et al
Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
PLoS One. 2022;17:e0276813.
PubMed Abstract available

Retraction: Upregulation of HYAL1 Expression in Breast Cancer Promoted Tumor Cell Proliferation, Migration, Invasion and Angiogenesis.
PLoS One. 2022;17:e0277500.
PubMed

SYED ALWI SM, Mazlan M, Mohd Taib NA, Che Din N, et al
A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
PLoS One. 2022;17:e0277056.
PubMed Abstract available

CRUZ SJV, Ribeiro AKPL, Pinheiro MDCN, Carneiro VCCB, et al
Five-year survival rate and prognostic factors in women with breast cancer treated at a reference hospital in the Brazilian Amazon.
PLoS One. 2022;17:e0277194.
PubMed Abstract available

XIE N, Shu Q, Wang Z, Huang X, et al
ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members.
PLoS One. 2022;17:e0274757.
PubMed Abstract available

LEE YL, Islam T, Danaee M, Taib NA, et al
A longitudinal study of physical activity among Malaysian breast cancer survivors.
PLoS One. 2022;17:e0277982.
PubMed Abstract available

HUTCHINGS HA, Remesh A
An evaluation of the readability and visual appearance of online patient resources for fibroadenoma.
PLoS One. 2022;17:e0277823.
PubMed Abstract available

JACKSON C, Finikarides L, Freeman ALJ
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
PLoS One. 2022;17:e0275321.
PubMed Abstract available

LUO J, Chen S, Chen J, Zhou Y, et al
Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
PLoS One. 2022;17:e0278270.
PubMed Abstract available

SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
PLoS One. 2022;17:e0278460.
PubMed Abstract available

TOMSIC S, Zagar T, Mihor A, Mlakar M, et al
Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening.
PLoS One. 2022;17:e0278384.
PubMed Abstract available

KIKAWA Y, Hagiwara Y, Fujisawa T, Araki K, et al
Health-related quality of life and estimation of the minimally important difference in the Functional Assessment of Cancer Therapy-Endocrine Symptom score in postmenopausal ER+/HER2- metastatic breast cancer with low sensitivity to endocrine therapy.
PLoS One. 2022;17:e0278344.
PubMed Abstract available

AMEEN F, AlNAdhari S, Al-Homaidan AA
Marine fungi showing multifunctional activity against human pathogenic microbes and cancer.
PLoS One. 2022;17:e0276926.
PubMed Abstract available

TUCKER JD, Doddapaneni R, Lu PJ, Lu QL, et al
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer.
PLoS One. 2022;17:e0278711.
PubMed Abstract available

LANKREW AYALEW T, Wale BG, Haile KE, Zewudie BT, et al
Health-related quality of life and associated factors among cancer patients in Ethiopia: Systematic review and meta-analysis.
PLoS One. 2022;17:e0277839.
PubMed Abstract available

GUNDOGMUS AG, Sezer Katar K, Orsel S, Ozturk G, et al
The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer.
PLoS One. 2022;17:e0277119.
PubMed Abstract available

ZHANG S, Wang H, Liu B, Yu J, et al
Socioeconomic status index is an independent determinant of breast cancer screening practices: Evidence from Eastern China.
PLoS One. 2022;17:e0279107.
PubMed Abstract available

CHOUPANI E, Madjd Z, Saraygord-Afshari N, Kiani J, et al
Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells.
PLoS One. 2022;17:e0279522.
PubMed Abstract available

QI SA, Kumar N, Xu JY, Patel J, et al
Personalized breast cancer onset prediction from lifestyle and health history information.
PLoS One. 2022;17:e0279174.
PubMed Abstract available

LING AY, Jreich R, Montez-Rath ME, Meng Z, et al
Transporting observational study results to a target population of interest using inverse odds of participation weighting.
PLoS One. 2022;17:e0278842.
PubMed Abstract available

TAHTAMOUNI L, Alzghoul A, Alderfer S, Sun J, et al
The role of activated androgen receptor in cofilin phospho-regulation depends on the molecular subtype of TNBC cell line and actin assembly dynamics.
PLoS One. 2022;17:e0279746.
PubMed Abstract available

DUTTA D, Sen A, Satagopan J
Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations.
PLoS One. 2022;17:e0276886.
PubMed Abstract available

PREMACHANDRA A, Wang X, Saad M, Moussawy S, et al
Erector spinae plane block versus thoracic paravertebral block for the prevention of acute postsurgical pain in breast cancer surgery: A prospective observational study compared with a propensity score-matched historical cohort.
PLoS One. 2022;17:e0279648.
PubMed Abstract available

January 2021

HADJIPANTELI A, Polyviou P, Kyriakopoulos I, Genagritis M, et al
Comparison of two-view versus single-view digital breast tomosynthesis and 2D-mammography in breast cancer surveillance imaging.
PLoS One. 2021;16:e0256514.
PubMed Abstract available

SANI L, Vispa A, Loretoni R, Duranti M, et al
Breast lesion detection through MammoWave device: Empirical detection capability assessment of microwave images' parameters.
PLoS One. 2021;16:e0250005.
PubMed Abstract available

JARM K, Kadivec M, Sval C, Hertl K, et al
Quality assured implementation of the Slovenian breast cancer screening programme.
PLoS One. 2021;16:e0258343.
PubMed Abstract available

SAKSORNCHAI K, Jaruthien T, Nantavithya C, Shotelersuk K, et al
Long-term results of hypofractionation with concomitant boost in patients with early breast cancer: A prospective study.
PLoS One. 2021;16:e0258186.
PubMed Abstract available

GARCIA MT, Mota BS, Cardoso N, Martimbianco ALC, et al
Accuracy of frozen section in intraoperative margin assessment for breast-conserving surgery: A systematic review and meta-analysis.
PLoS One. 2021;16:e0248768.
PubMed Abstract available

XIE Y, Guo B, Zhang R
Cost-effectiveness analysis of radiotherapy techniques for whole breast irradiation.
PLoS One. 2021;16:e0248220.
PubMed Abstract available

MOHAMED RI, Bargal SA, Mekawy AS, El-Shiekh I, et al
The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.
PLoS One. 2021;16:e0247837.
PubMed Abstract available

PARK JH, Jung YS, Kim JY, Bae SH, et al
Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study.
PLoS One. 2021;16:e0258447.
PubMed Abstract available

STONE JK, Vukadin L, Ahn EE
eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
PLoS One. 2021;16:e0251515.
PubMed Abstract available

ZOELLER JJ, Press MF, Selfors LM, Dering J, et al
Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy.
PLoS One. 2021;16:e0251163.
PubMed Abstract available

BLASI MA, Maceroni M, Caputo CG, Sammarco MG, et al
Clinical and ultrasonographic features of choroidal metastases based on primary cancer site: Long-term experience in a single center.
PLoS One. 2021;16:e0249210.
PubMed Abstract available

JAMES JE, Riddle L, Koenig BA, Joseph G, et al
The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial.
PLoS One. 2021;16:e0258571.
PubMed Abstract available

OPOKU F, Bedu-Addo K, Titiloye NA, Atta Manu E, et al
Expression profile of tumour suppressor protein p53 and its regulator MDM2 in a cohort of breast cancer patients in a Tertiary Hospital in Ghana.
PLoS One. 2021;16:e0258543.
PubMed Abstract available

JENSEN MD, Hansen KM, Siersma V, Brodersen J, et al
Using a Deliberative Poll on breast cancer screening to assess and improve the decision quality of laypeople.
PLoS One. 2021;16:e0258869.
PubMed Abstract available

BROCK EJ, Jackson RM, Boerner JL, Li Q, et al
Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma.
PLoS One. 2021;16:e0252314.
PubMed Abstract available

AGODIRIN O, Olatoke S, Rahman G, Kolawole O, et al
Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.
PLoS One. 2021;16:e0256847.
PubMed Abstract available

MARES AG, Pacassoni G, Marti JS, Pujals S, et al
Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology.
PLoS One. 2021;16:e0251821.
PubMed Abstract available

AMIRFALLAH A, Knutsdottir H, Arason A, Hilmarsdottir B, et al
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
PLoS One. 2021;16:e0260327.
PubMed Abstract available

QIU P, Guo Q, Yao Q, Chen J, et al
Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
PLoS One. 2021;16:e0254283.
PubMed Abstract available

HANSEN JA, Naghavi-Behzad M, Gerke O, Baun C, et al
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy.
PLoS One. 2021;16:e0260066.
PubMed Abstract available

WU WP, Chen CY, Lee CW, Wu HK, et al
Impact of pre-operative breast magnetic resonance imaging on contralateral synchronous and metachronous breast cancer detection-A case control comparison study with 1468 primary operable breast cancer patients with mean follow-up of 102 months.
PLoS One. 2021;16:e0260093.
PubMed Abstract available

DARGA EP, Dolce EM, Fang F, Kidwell KM, et al
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
PLoS One. 2021;16:e0260124.
PubMed Abstract available

MEKONEN S, Ibrahim M, Astatkie H, Abreha A, et al
Correction: Exposure to organochlorine pesticides as a predictor to breast cancer: A case-control study among Ethiopian women.
PLoS One. 2021;16:e0260106.
PubMed Abstract available

EZZALFANI M, Porcher R, Savignoni A, Delaloge S, et al
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.
PLoS One. 2021;16:e0255017.
PubMed Abstract available

KAGAYA Y, Arikawa M, Sekiyama T, Mitsuwa H, et al
The concept of "whole perforator system" in the lateral thoracic region for latissimus dorsi muscle-preserving large flaps: An anatomical study and case series.
PLoS One. 2021;16:e0256962.
PubMed Abstract available

PRATOOMCHART C, Klunklin P, Wanwilairat S, Nobnop W, et al
The advantages of abdominal compression with shallow breathing during left-sided postmastectomy radiotherapy by Helical TomoTherapy.
PLoS One. 2021;16:e0254934.
PubMed Abstract available

HE Q, Cheng G, Ju H
BCDnet: Parallel heterogeneous eight-class classification model of breast pathology.
PLoS One. 2021;16:e0253764.
PubMed Abstract available

GUO Y, Duan X, Wang C, Guo H, et al
Segmentation and recognition of breast ultrasound images based on an expanded U-Net.
PLoS One. 2021;16:e0253202.
PubMed Abstract available

GHANBARI S, Salimi A, Rahmani S, Nafissi N, et al
miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues.
PLoS One. 2021;16:e0253009.
PubMed Abstract available

HARTMANN B, Muller M, Seyler L, Bauerle T, et al
Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla.
PLoS One. 2021;16:e0252935.
PubMed Abstract available

EASLEY TO, Ren Z, Kim B, Karczmar GS, et al
Enhancement-constrained acceleration: A robust reconstruction framework in breast DCE-MRI.
PLoS One. 2021;16:e0258621.
PubMed Abstract available

MARRIE RA, Walld R, Bolton JM, Sareen J, et al
Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
PLoS One. 2021;16:e0249809.
PubMed Abstract available

BRUCKMANN NM, Kirchner J, Morawitz J, Umutlu L, et al
Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results.
PLoS One. 2021;16:e0260804.
PubMed Abstract available

ADEYEMI OJ, Gill TL, Paul R, Huber LB, et al
Evaluating the association of self-reported psychological distress and self-rated health on survival times among women with breast cancer in the U.S.
PLoS One. 2021;16:e0260481.
PubMed Abstract available

CHOI W, Lee H
Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
PLoS One. 2021;16:e0258626.
PubMed Abstract available

ALACHRAM H, Chereda H, Beissbarth T, Wingender E, et al
Text mining-based word representations for biomedical data analysis and protein-protein interaction networks in machine learning tasks.
PLoS One. 2021;16:e0258623.
PubMed Abstract available

SHAMMOUT ODA, Ashmawy NS, Shakartalla SB, Altaie AM, et al
Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
PLoS One. 2021;16:e0258363.
PubMed Abstract available

KEETILE M, Ndlovu K, Letamo G, Disang M, et al
Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
PLoS One. 2021;16:e0255581.
PubMed Abstract available

LENG X, Huang G, Li S, Yao M, et al
Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).
PLoS One. 2021;16:e0261138.
PubMed Abstract available

SON Y, Han K, Lee YS, Yu J, et al
Privacy-preserving breast cancer recurrence prediction based on homomorphic encryption and secure two party computation.
PLoS One. 2021;16:e0260681.
PubMed Abstract available

POLITI MC, Saunders CH, Grabinski VF, Yen RW, et al
An absence of equipoise: Examining surgeons' decision talk during encounters with women considering breast cancer surgery.
PLoS One. 2021;16:e0260704.
PubMed Abstract available

ZHOU Z, Li J, Wang H, Luan Z, et al
Upper limb rehabilitation system based on virtual reality for breast cancer patients: Development and usability study.
PLoS One. 2021;16:e0261220.
PubMed Abstract available

FOMITCHEVA-KHARTCHENKO A, Rapsomaniki MA, Sobottka B, Schraml P, et al
Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
PLoS One. 2021;16:e0259332.
PubMed Abstract available

ZIMMERMANN RC, Sardiu ME, Manton CA, Miah MS, et al
Perturbation of BRMS1 interactome reveals pathways that impact metastasis.
PLoS One. 2021;16:e0259128.
PubMed Abstract available

SUN Y, Ji Y
AAWS-Net: Anatomy-aware weakly-supervised learning network for breast mass segmentation.
PLoS One. 2021;16:e0256830.
PubMed Abstract available

BREDNO J, Lipson J, Venn O, Aravanis AM, et al
Clinical correlates of circulating cell-free DNA tumor fraction.
PLoS One. 2021;16:e0256436.
PubMed Abstract available

HE X, Anthony DC, Catoni Z, Cao W, et al
Pulmonary tumor embolism: A retrospective study over a 30-year period.
PLoS One. 2021;16:e0255917.
PubMed Abstract available

LIN KH, Hsu HM, Hsu KF, Chu CH, et al
Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study.
PLoS One. 2021;16:e0261258.
PubMed Abstract available

HU Y, Zou D
Combined mRNAs and clinical factors model on predicting prognosis in patients with triple-negative breast cancer.
PLoS One. 2021;16:e0260811.
PubMed Abstract available

AWODUTIRE PO, Balogun OS, Olapade AK, Nduka EC, et al
The modified beta transmuted family of distributions with applications using the exponential distribution.
PLoS One. 2021;16:e0258512.
PubMed Abstract available

CHANG YY, Lin HJ, Hsiao LC, Lin YF, et al
Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect.
PLoS One. 2021;16:e0260533.
PubMed Abstract available

TANAKA M, Tanaka T, Takamatsu M, Shibue C, et al
Effects of the Kampo medicine Yokukansan for perioperative anxiety and postoperative pain in women undergoing breast surgery: A randomized, controlled trial.
PLoS One. 2021;16:e0260524.
PubMed Abstract available

KAUR P, Nagar S, Bhagwat M, Uddin M, et al
Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
PLoS One. 2021;16:e0260400.
PubMed Abstract available

ZHANG X, Kschischo M
MFmap: A semi-supervised generative model matching cell lines to tumours and cancer subtypes.
PLoS One. 2021;16:e0261183.
PubMed Abstract available

OZGENCIL M, Barwell J, Tischkowitz M, Izatt L, et al
Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance.
PLoS One. 2021;16:e0260852.
PubMed Abstract available

HIRAMOTO S, Asano H, Miyamoto T, Takegami M, et al
Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan.
PLoS One. 2021;16:e0261473.
PubMed Abstract available

VELAZQUEZ FN, Zhang L, Viscardi V, Trocchia C, et al
Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
PLoS One. 2021;16:e0252311.
PubMed Abstract available

KIM HS, Kim MG, Min KW, Jung US, et al
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
PLoS One. 2021;16:e0252052.
PubMed Abstract available

BADAWY SM, Mohamed AEA, Hefnawy AA, Zidan HE, et al
Automatic semantic segmentation of breast tumors in ultrasound images based on combining fuzzy logic and deep learning-A feasibility study.
PLoS One. 2021;16:e0251899.
PubMed Abstract available

HOLTDIRK F, Mehnert A, Weiss M, Mayer J, et al
Results of the Optimune trial: A randomized controlled trial evaluating a novel Internet intervention for breast cancer survivors.
PLoS One. 2021;16:e0251276.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.